Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancer-Reference-Cited by-同舟云学术

Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancer

Published:2006 Issue:11 Volume:118 Page:2790-2795
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bourquin Carole,Schreiber Susanne,Beck Sebastian,Hartmann Gunther,Endres Stefan

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference40 articles.

1. Cancer Immunotherapy: A Treatment for the Masses

2. Interplay Between the Toxic Effects of Anticancer Drugs and Host Antitumor Immunity in Cancer Therapy

3. The effect of immunosuppressive chemotherapy on immune function in patients with malignant disease

4. Severe immunodeficiency in patients treated with fludarabine monophosphate

5. CpG motifs in bacterial DNA trigger direct B-cell activation

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IDO Inhibitor and Gallic Acid Cross-Linked Small Molecule Drug Synergistic Treatment of Melanoma;Frontiers in Oncology;2022-07-01

2. Multifunctional injectable hydrogels for three-in-one cancer therapy: Preoperative remission via mild photothermal-enhanced supramolecular chemotherapy and prevention of postoperative recurrence and adhesion;Chemical Engineering Journal;2021-12

3. Class A CpG oligodeoxynucleotide inhibits IFN‐γ‐induced signaling and apoptosis in lung cancer;Thoracic Cancer;2020-04

4. Role of microbial dysbiosis in carcinogenesis & cancer therapies;Indian Journal of Medical Research;2020

5. A mathematical model of tumour growth with Beddington–DeAngelis functional response: a case of cancer without disease;Journal of Biological Dynamics;2018-01-01